Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Return on Capital Employed: 2011-2025

Historic Return on Capital Employed for Fennec Pharmaceuticals (FENC) over the last 12 years, with Sep 2025 value amounting to -0.13%.

  • Fennec Pharmaceuticals' Return on Capital Employed fell 16.00% to -0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.13%, marking a year-over-year decrease of 16.00%. This contributed to the annual value of 0.09% for FY2024, which is 75.00% up from last year.
  • Fennec Pharmaceuticals' Return on Capital Employed amounted to -0.13% in Q3 2025, which was up 51.84% from -0.26% recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Return on Capital Employed registered a high of 0.16% during Q1 2024, and its lowest value of -1.63% during Q2 2023.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.26% (2025), whereas its average is -0.50%.
  • As far as peak fluctuations go, Fennec Pharmaceuticals' Return on Capital Employed slumped by 55bps in 2023, and later surged by 173bps in 2024.
  • Fennec Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.65% in 2021, then tumbled by 37bps to -1.08% in 2022, then climbed by 28bps to -0.80% in 2023, then soared by 86bps to 0.06% in 2024, then decreased by 16bps to -0.13% in 2025.
  • Its Return on Capital Employed stands at -0.13% for Q3 2025, versus -0.26% for Q2 2025 and -0.32% for Q1 2025.